levodopa has been researched along with Melanoma in 121 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 67 (55.37) | 18.7374 |
1990's | 23 (19.01) | 18.2507 |
2000's | 17 (14.05) | 29.6817 |
2010's | 12 (9.92) | 24.3611 |
2020's | 2 (1.65) | 2.80 |
Authors | Studies |
---|---|
Fujita, K; Inoue, S; Ito, S; Yamamoto, Y | 1 |
Guillén Climent, S; Monteagudo, C; Pinazo Canales, MI; Porcar Saura, S | 1 |
Cardoso, R; da S Gonçalves Vianez, JL; de Molfetta, FA; Nahum Alves, C; Santana da Costa, K; Souza da Costa, CH; Valente, R | 1 |
Jeong, H; Kim, D; Kim, K; Leutou, AS; Lim, KM; Nam, SJ; Seong, CN | 1 |
Almeida, MA; Chaves, OA; de Oliveira, MCC; Echevarria, A; Marins-Goulart, C; Soares, MA | 1 |
Bakker, WJ; Kammeyer, A; Luiten, RM; Ouwerkerk, W; Pronk, SD; Ratsma, D; Smit, NPM; Willemsen, KJ | 1 |
Mansouri, K; Razlansari, M; Shahabadi, N; Zhaleh, H | 1 |
Barth, RF; Chandra, S; Haider, SA; Huo, T; Kabalka, GW; Shaikh, AL; Yang, W | 1 |
Bhin, J; Bin, BH; Cho, EG; Choi, DH; Hwang, D; Lee, AY; Lee, TR; Park, K; Shin, DW; Yang, SH | 1 |
Disse, M; Lee, PK; Reich, H; Schram, SS | 1 |
Trip, J; Vermeij, JD; Weber, WE; Winogrodzka, A | 1 |
Charles, J; Lantuejoul, S; Leccia, MT; Leroux, D; Robert, C; Salameire, D; Templier, I | 1 |
Inzelberg, R; Israeli-Korn, SD | 1 |
Houlden, H; Paisán-Ruiz, C | 1 |
Kawano, Y; Yamazaki, Y | 1 |
Gao, X; Ning, Y | 1 |
Pawelek, J; Slominski, A; Zmijewski, MA | 1 |
Che, CT; Cheung, FWK; Guo, J; Ling, YH; Liu, WK | 1 |
Bousquet, B; Garnier, JP; Ghanem, G; Le Bricon, T; Letellier, S; Morel, P; Stoitchkov, K; Tsankov, N | 2 |
Fiala, KH; Manyam, BV; Whetteckey, J | 1 |
Loria, D; Rosso, S; Zanetti, R | 1 |
Bressac de Paillerets, B; Charles, J; Combe, MC; Leccia, MT; Leroux, D; Templier, I | 1 |
Rosso, S; Zanetti, R | 1 |
Baccard, M; Basset-Seguin, N; Bousquet, B; Cassinat, B; Dubertret, L; Garnier, JP; Kerob, D; Le Bricon, T; Lebbé, C; Letellier, S; Morel, P; Stoitchkov, K | 1 |
Constantinescu, R; Kieburtz, K; Romer, M | 1 |
Avril, MF; Bonadona, V; Bressac-de Paillerets, B; Chompret, A; Dalle, S; Kannengiesser, C; Lasset, C; Leccia, MT; Lenoir, G; Leroux, D; Lesueur, F; Sarasin, A; Thomas, L | 1 |
Frederiksen, K; Friis, S; Olsen, JH; Tangerud, K; Wermuth, L | 1 |
Loria, DI; Rosso, S; Zanetti, R | 1 |
Boekelheide, K; Graham, DG; Koo, EH; Mize, PD | 1 |
Hakim, AA | 1 |
Busse, E; Riessbeck, KH; Rose, H | 1 |
Jergil, B; Lindbladh, C; Rorsman, H; Rosengren, E | 1 |
Fitzpatrick, TB; Harrist, TJ; Melski, JW; Mihm, MC; Rhodes, AR; Sober, AJ | 1 |
DiSorbo, DM; Harris, NA; Nathanson, L | 1 |
Lukács, L; Menyhei, G; Péter, S | 1 |
Blagoeva, PM | 1 |
Celis, JE | 1 |
Hendrix, MJ; Meyskens, FL; Persky, B | 1 |
Bomirski, A; Scisłowski, PW; Słomiński, A | 1 |
Braun, M; Rosin, MA | 1 |
Wick, MM | 6 |
Lubahn, DB; McCarty, KS; Seigler, HF; Stowers, S; Wortman, J | 1 |
Fujita, K; Ito, S; Teradaira, R | 1 |
Meadows, GG; Pierson, HF | 2 |
Ali, FM; Black, M; Camp, VM; Faraj, BA; Lawson, DH; Murray, DR; Nixon, DW; Stacciarini, W; Tarcan, Y | 1 |
Krummel, TM; Neifeld, JP; Taub, RN | 1 |
Thiers, BH | 1 |
Abdallah, RM; Desai, PR; Meadows, GG; Pierson, HF | 1 |
Brihaye-Van Geertruyden, MF; De Jong, PT; Demols, EE; Van Rens, GH | 1 |
Bowers, RR; Hadfield, TL; Shieh, SJ | 1 |
Gilbert, EF; Ramirez, G; Warner, TF | 1 |
Bernstein, JE; Lorincz, AL; Medenica, M; Solomon, A; Soltani, K | 1 |
Karhunen, T; Pavel, S; Slingerland, R; Smit, N; Tilgmann, C; Ulmanen, I; Westerhof, W | 1 |
Arakawa, H; Funayama, M; Murao, S; Nishino, T; Shin, T; Yamamoto, R | 1 |
Fujita, K; Hasegawa, K; Inoue, S; Ito, S; Jiménez-Cervantes, C; Ozeki, H; Solano, F; Wakamatsu, K | 1 |
Goldenberg, JN; Sanchez-Ramos, JR; Singer, C; Weiner, WJ | 1 |
Larsson, BS; Mårs, U | 1 |
Burg, G; Kleinhans, M; Schmid-Grendelmeier, P | 1 |
Pfützner, W; Przybilla, B | 1 |
Bousquet, B; Garnier, JP; Letellier, S; Spy, J | 1 |
Manyam, BV; Woofter, MJ | 1 |
Michiels, JF; Ortonne, JP; Perrin, C; Pisani, A | 1 |
Rampen, F | 1 |
Baccard, M; Bousquet, B; Garnier, JP; Kerneis, Y; Le Bricon, T; Letellier, S; Revol, M; Spy, J; Stoitchkov, K | 1 |
Dizdar, N; Granérus, AK; Hannestad, U; Kågedal, B; Kullman, A; Ljungdahl, A; Olsson, JE | 1 |
Rosenblatt, BK; Schneider, DC; Siple, JF; Wanlass, WA | 1 |
Borel Rinkes, IH; Hamoen, KE; Morgan, JR | 1 |
Clement, MV; Halliwell, B; Long, LH; Ramalingam, J | 1 |
Li, JP; Pomerantz, SH | 1 |
Delaney, P; Fermaglich, J | 2 |
Cogniaux, J; Doyen, A; Frühling, J; Liteanu, D; Van Tieghem, N | 1 |
Yahr, MD | 1 |
Lee, MS; Lee, TH | 1 |
Borovanský, J; Duchon, J; Pavel, S; Vulterin, K | 1 |
Gorman, M; Kramer, RA; Wick, MM | 1 |
Sober, AJ; Wick, MM | 1 |
Botteri, A; Nordström, PO | 1 |
Maat, B | 1 |
Frei, E; Wick, MM | 1 |
Byers, L; Frei, E; Wick, MM | 1 |
Bornstein, B; Kott, E; Shohat, B | 1 |
Pelfréne, AF | 1 |
Haider, SA; Thaller, VT | 1 |
Pruski, D; Slominski, A | 1 |
Esteguy, M; Leiguarda, R; Merello, M; Perazzo, F | 1 |
Schallreuter, KU; Wood, JM | 1 |
Karg, E; Rorsman, H; Rosengren, E | 1 |
Costantino, R; Slominski, A | 1 |
Slominski, A | 1 |
D'iakov, VL; Iakh''iaev, AV; Lalaev, VV; Sukhanov, VA | 1 |
Coates, A; Gurney, H; Kefford, R | 1 |
Ito, S; Kasuga, T; Matsubara, O; Seki, S; Suzuki, S; Yamada, I | 2 |
Braun-Falco, O; Landthaler, M; Przybilla, B; Schwab, U | 1 |
Kande'l, EI | 1 |
Favier, D; Kable, EP; Parsons, PG | 1 |
McLane, J; Osber, M; Pawelek, JM | 1 |
Kable, EP; Parsons, PG | 1 |
Murray, M; Pawelek, JM | 1 |
Breathnach, A; Faggioni, A; Nazzaro-Porro, M; Passi, S; Picardo, M; Riley, P; Zompetta, C | 1 |
Maggini, M; Morpurgo, G | 1 |
Bomirski, A; Kuklinska, E; Moellmann, G; Pawelek, J; Słominski, A | 1 |
Aime, S; Crippa, PR | 1 |
Fukunaga, M; Furukawa, T; Kawada, M; Mitsumori, M; Muranaka, A; Nagai, K; Ono, S; Otsuka, N; Tomomitsu, T; Yanagimoto, S | 1 |
Abdallah, RM; Meadows, GG; Starkey, JR | 1 |
Berjian, RA; Bhakoo, HS; Kanter, PM; Lawrence, DD; Tan, MH | 1 |
García-Borrón, JC; Iborra, JL; Lozano, JA; Martínez, JH; Solano, F | 1 |
Camp, VM; Faraj, BA; Hearn, J; Kutner, M; Murray, DR; Nixon, D | 1 |
Rampen, FH | 1 |
Kochar, AS | 1 |
Castagnoli, N; Epstein, WL; Fukuyama, K; Gellin, GA; Halldin, MM; Kawashima, T | 1 |
Bomirski, A; Scisłowski, PW; Słomiński, A; Zydowo, M | 1 |
14 review(s) available for levodopa and Melanoma
Article | Year |
---|---|
A Review of the Association Between Parkinson Disease and Malignant Melanoma.
Topics: Antiparkinson Agents; Environment; Genetic Predisposition to Disease; Humans; Levodopa; Melanoma; Parkinson Disease; Risk Factors; Skin Neoplasms; Skin Pigmentation | 2016 |
Parkinson's disease, levodopa-use and the risk of melanoma.
Topics: Animals; Humans; Levodopa; Melanoma; Parkinson Disease; Risk Factors; Skin Neoplasms | 2009 |
The particular relationship between Parkinson's disease and malignancy: a focus on skin cancers.
Topics: Antiparkinson Agents; Causality; Comorbidity; Humans; Levodopa; Mass Screening; Melanoma; Parkinson Disease; Risk Factors; Skin Neoplasms | 2009 |
Cancer and Parkinson's disease: the odd couple.
Topics: Humans; Levodopa; Life Style; Melanoma; Neoplasms; Parkinson Disease; Smoking; Social Class | 2011 |
L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions.
Topics: Animals; Humans; Levodopa; Melanins; Melanocytes; Melanoma; Models, Biological; Monophenol Monooxygenase; Oxidative Stress; Skin Neoplasms; Structure-Activity Relationship; Tyrosine | 2012 |
Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Melanoma; Middle Aged; Parkinson Disease; Retrospective Studies; Skin Neoplasms | 2003 |
Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature.
Topics: Animals; Humans; Levodopa; Melanoma; Mice; Parkinson Disease; Skin Neoplasms | 2006 |
Parkinson's disease and cancer.
Topics: Antiparkinson Agents; Cohort Studies; Humans; Levodopa; Melanoma; Neoplasms; Parkinson Disease | 2007 |
Levodopa, melanoma, and Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Contraindications; Female; Follow-Up Studies; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Parkinson Disease; Skin Neoplasms | 1993 |
[Levodopa and malignant melanoma--case report and review of the literature. A contribution to causal relationship between levodopa and the development of malignant melanoma].
Topics: Aged; Antiparkinson Agents; Cell Transformation, Neoplastic; Humans; Levodopa; Long-Term Care; Male; Melanoma; Parkinson Disease; Skin; Skin Neoplasms | 1996 |
Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature.
Topics: Aged; Antiparkinson Agents; Back; Biopsy; Humans; Levodopa; Male; Melanoma; Middle Aged; Nose Neoplasms; Parkinson Disease; Skin; Skin Neoplasms | 1997 |
Levodopa therapy and the risk of malignant melanoma.
Topics: Antiparkinson Agents; Humans; Levodopa; Melanoma; Parkinson Disease | 2000 |
Levodopa.
Topics: Benserazide; Drug Interactions; Hepatic Encephalopathy; Humans; Huntington Disease; Levodopa; Melanoma; Parkinson Disease; Pituitary Function Tests | 1975 |
[Melanoma as a possible complication of the treatment of parkinsonism with L-dopa preparations (review of the literature)].
Topics: Humans; Levodopa; Melanoma; Parkinson Disease; Skin Neoplasms | 1989 |
1 trial(s) available for levodopa and Melanoma
Article | Year |
---|---|
Treatment with levodopa and risk for malignant melanoma.
Topics: Antiparkinson Agents; Case-Control Studies; Female; Follow-Up Studies; Humans; Incidence; Levodopa; Male; Melanoma; Odds Ratio; Parkinson Disease; Retrospective Studies; Risk | 2007 |
106 other study(ies) available for levodopa and Melanoma
Article | Year |
---|---|
Synthesis and antitumor activity of cysteinyl-3,4-dihydroxyphenylalanines and related compounds.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cricetinae; Cysteinyldopa; Dihydroxyphenylalanine; Humans; Leukemia L1210; Male; Melanoma; Mice; Neoplasms, Experimental; Neuroblastoma | 1981 |
Melanocytic Hyperactivation Simulating an Acral Lentiginous Melanoma in a Patient With Parkinson Disease Treated by Levodopa.
Topics: Aged; Antiparkinson Agents; Carbidopa; Diagnosis, Differential; Drug Combinations; Female; Humans; Hyperpigmentation; Levodopa; Melanins; Melanocytes; Melanoma; Parkinson Disease; Predictive Value of Tests; Skin; Skin Neoplasms; Skin Pigmentation; Treatment Outcome | 2021 |
Analysis of Kojic Acid Derivatives as Competitive Inhibitors of Tyrosinase: A Molecular Modeling Approach.
Topics: Catalytic Domain; Enzyme Inhibitors; Humans; Levodopa; Melanins; Melanocytes; Melanoma; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Monophenol Monooxygenase; Pyrones; Skin Neoplasms; Structure-Activity Relationship; Tyrosine | 2021 |
Anti-Pigmentary Effect of (-)-4-Hydroxysattabacin from the Marine-Derived Bacterium Bacillus sp.
Topics: Animals; Aquatic Organisms; Bacillus; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Epidermis; Hexanones; Humans; Levodopa; Melanins; Melanoma; Mice; Molecular Structure; Pigmentation | 2017 |
Thiosemicarbazones as inhibitors of tyrosinase enzyme.
Topics: Agaricales; Enzyme Inhibitors; Humans; Levodopa; Melanins; Melanoma; Molecular Docking Simulation; Monophenol Monooxygenase; Thiosemicarbazones | 2017 |
Mechanism of action of 4-substituted phenols to induce vitiligo and antimelanoma immunity.
Topics: Biological Assay; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Humans; Immunity; Levodopa; Lymphocyte Activation; Melanins; Melanoma; Melanosomes; Monophenol Monooxygenase; Phenols; Protein Binding; Quinones; Sulfhydryl Compounds; Vitiligo | 2019 |
Antiproliferative effects of new magnetic pH-responsive drug delivery system composed of Fe
Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Hydroxides; Levodopa; Melanoma | 2019 |
Effects of l-DOPA pre-loading on the uptake of boronophenylalanine using the F98 glioma and B16 melanoma models.
Topics: Animals; Boron Compounds; Brain Neoplasms; Drug Synergism; Female; Glioma; Levodopa; Melanoma; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Organ Specificity; Phenylalanine; Premedication; Tissue Distribution; Treatment Outcome | 2014 |
Hyperosmotic stress reduces melanin production by altering melanosome formation.
Topics: Antiparkinson Agents; Blotting, Western; Cell Line, Tumor; Cluster Analysis; Gene Expression Profiling; gp100 Melanoma Antigen; Humans; Levodopa; Melanins; Melanocytes; Melanoma; Melanosomes; Membrane Glycoproteins; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Oligonucleotide Array Sequence Analysis; Osmotic Pressure; Oxidoreductases; Phosphatidylinositol 3-Kinases; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Vacuoles | 2014 |
Twenty-two cutaneous primary melanomas in a patient with high genetic predisposition to melanoma receiving levodopa therapy for Parkinson's disease.
Topics: DNA Mutational Analysis; Genetic Predisposition to Disease; Humans; Levodopa; Male; Melanoma; Middle Aged; Parkinson Disease; Skin Neoplasms; Ultraviolet Rays | 2009 |
Common pathogenic pathways in melanoma and Parkinson disease.
Topics: Brain Neoplasms; Group VI Phospholipases A2; Humans; Levodopa; Melanoma; Neural Pathways; Parkinson Disease; Tyrosine | 2010 |
N-(3,5-dihydroxybenzoyl)-6-hydroxytryptamine as a novel human tyrosinase inhibitor that inactivates the enzyme in cooperation with l-3,4-dihydroxyphenylalanine.
Topics: Cell Line, Tumor; Enzyme Inhibitors; Humans; Levodopa; Melanoma; Monophenol Monooxygenase; Serotonin | 2010 |
Anti-melanogenic property of geoditin A in murine B16 melanoma cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Endoplasmic Reticulum; Geodia; Glycosylation; Inhibitory Concentration 50; Levodopa; Lysosomes; Melanins; Melanoma; Mice; Monophenol Monooxygenase; Neoplasm Proteins; Protein Processing, Post-Translational; Reactive Oxygen Species; Resorcinols; Triterpenes | 2012 |
Melanoma progression and serum L-dopa/L-tyrosine ratio: a comparison with S100B.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Bulgaria; Chromatography, High Pressure Liquid; Disease Progression; Female; Follow-Up Studies; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Nerve Growth Factors; Predictive Value of Tests; Prognosis; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Tyrosine | 2002 |
Evaluation of the serum L-dopa/L-tyrosine ratio as a melanoma marker.
Topics: Adult; Biomarkers, Tumor; Cell Line, Tumor; Chromatography, High Pressure Liquid; Female; Humans; Levodopa; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nerve Growth Factors; Prognosis; Recurrence; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Time Factors; Tyrosine | 2003 |
[CDKN2A gene mutation and loss of p16 protein activity in a patient on levodopa presenting sporadic multiple primary melanoma].
Topics: Antiparkinson Agents; Cyclin-Dependent Kinase Inhibitor p16; Genes, p16; Humans; Levodopa; Male; Melanoma; Middle Aged; Mutation; Skin Neoplasms | 2006 |
Levodopa and the risk of melanoma.
Topics: Antiparkinson Agents; Case-Control Studies; Humans; Levodopa; Melanoma; Parkinson Disease; Registries; Risk Factors; Smoking | 2007 |
Clinical value of combined determination of plasma L-DOPA/tyrosine ratio, S100B, MIA and LDH in melanoma.
Topics: Aged; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Female; Humans; Levodopa; Male; Melanoma; Middle Aged; Prospective Studies; S100 Proteins; Sensitivity and Specificity; Skin Neoplasms; Survival Analysis; Tyrosine | 2007 |
Malignant melanoma in early Parkinson's disease: the DATATOP trial.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Cohort Studies; Comorbidity; Cross-Sectional Studies; Female; Humans; Incidence; Levodopa; Male; Melanoma; Middle Aged; Multicenter Studies as Topic; Parkinson Disease; Randomized Controlled Trials as Topic; Reference Values; Retrospective Studies; Skin Neoplasms | 2007 |
New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment.
Topics: DNA Mutational Analysis; Family; Family Health; Founder Effect; France; Gene Frequency; Genes, p16; Germ-Line Mutation; Haplotypes; Humans; Levodopa; Melanoma; Pedigree | 2007 |
Melanocytotoxicity and the mechanism of activation of gamma-L-glutaminyl-4-hydroxybenzene.
Topics: Aminophenols; Animals; Cattle; Enzyme Activation; gamma-Glutamyltransferase; Glutamine; Hydroxylation; Levodopa; Melanocytes; Melanoma; Mice; Monophenol Monooxygenase; Tritium | 1980 |
Correlation between tyrosine hydroxylase activity, melanogenesis, and estradiol binding in human melanoma cells.
Topics: Breast Neoplasms; Cell Line; Cytosol; Estradiol; Fibroblasts; Humans; Kinetics; Levodopa; Melanins; Melanoma; Tamoxifen; Tyrosine; Tyrosine 3-Monooxygenase | 1982 |
[Effect of the cAMP and interferon levels in the lymphocytes and on a change in the tumor growth rate of a transplantable golden hamster melanoma after BCG, measles vaccine, L-DOPA and amantadine treatment].
Topics: Amantadine; Animals; BCG Vaccine; Cricetinae; Cyclic AMP; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Interferons; Levodopa; Lymph Nodes; Lymphocytes; Measles Vaccine; Melanoma; Mesocricetus; Neoplasm Transplantation; Neoplasms, Experimental | 1980 |
Inactivation of human tyrosinase by cysteine. Protection by dopa and tyrosine.
Topics: Catalase; Catechol Oxidase; Cells, Cultured; Cysteine; Humans; In Vitro Techniques; Levodopa; Melanoma; Monophenol Monooxygenase; Superoxide Dismutase; Tyrosine | 1984 |
Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines.
Topics: Adult; Aged; Female; Histological Techniques; Humans; Lentigo; Levodopa; Male; Melanocytes; Melanoma; Middle Aged; Nevus; Paraffin; Skin; Skin Neoplasms | 1983 |
Effect of triamcinolone acetonide on tyrosinase activity in a human melanoma cell line.
Topics: Carbon Radioisotopes; Catechol Oxidase; Cell Cycle; Cell Line; DNA Replication; Humans; Kinetics; Levodopa; Melanoma; Monophenol Monooxygenase; Triamcinolone Acetonide; Tritium; Tyrosine | 1984 |
[Serum L-DOPA oxidase activity in patients with malignant cutaneous melanoma].
Topics: Adult; Female; Humans; Levodopa; Male; Melanoma; Middle Aged; Oxidoreductases; Skin Neoplasms | 1984 |
Aminoacids--precursors of melanin synthesis in hamster melanoma.
Topics: Amino Acids; Animals; Cricetinae; Ferrous Compounds; Iron; Levodopa; Male; Melanins; Melanoma; Mesocricetus; Neoplasm Transplantation; Phenylalanine; Tryptophan; Tyrosine | 1984 |
Expression of mRNAs microinjected into somatic cells.
Topics: Animals; Cell Division; Cells, Cultured; Globins; Levodopa; Melanins; Melanoma; Mice; Microinjections; Protein Biosynthesis; RNA, Messenger | 1984 |
Diagnostic electron microscopy for amelanotic melanoma: correlation of patient biopsy, soft agar assay, and xenograft.
Topics: Adult; Agar; Animals; Biopsy; Cells, Cultured; Humans; Levodopa; Male; Melanoma; Mice; Mice, Nude; Microscopy, Electron; Neoplasm Transplantation; Transplantation, Heterologous | 1983 |
Biochemical characterization of three hamster melanoma variants--II. Glycolysis and oxygen consumption.
Topics: Animals; Cricetinae; Glycolysis; Lactates; Levodopa; Melanoma; Mesocricetus; Neoplasm Transplantation; Oxygen Consumption | 1984 |
Malignant melanoma and levodopa.
Topics: Humans; Levodopa; Male; Melanins; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Nevus; Skin Neoplasms | 1984 |
Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma.
Topics: Animals; Cell Membrane Permeability; Cells, Cultured; DNA, Neoplasm; Dopamine; Humans; Levodopa; Melanoma; Mice; Monophenol Monooxygenase; Neoplasms, Experimental; Nucleic Acid Synthesis Inhibitors; Quinones | 1980 |
Sex steroid receptor analysis in human melanoma.
Topics: Adult; Aged; Estradiol; Estrogen Antagonists; Female; Humans; Levodopa; Male; Melanins; Melanoma; Middle Aged; Monophenol Monooxygenase; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid; Tyrosine | 1980 |
Distribution and metabolism of tritiumlabelled 5-S-cysteinyldopa in mice.
Topics: Animals; Cysteinyldopa; Dihydroxyphenylalanine; Levodopa; Male; Melanoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Tissue Distribution | 1980 |
Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma.
Topics: Animals; Antineoplastic Agents; Ascorbic Acid; Carbidopa; Cell Line; Diet; Drug Synergism; Drug Therapy, Combination; Female; Injections, Intraperitoneal; Levodopa; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Phenylalanine; Tyrosine | 1983 |
The chemotherapy of malignant melanoma.
Topics: Carbidopa; Cardiovascular Diseases; Dopamine; Drug Evaluation; Humans; Levodopa; Melanoma; Mitotic Index; Skin Neoplasms | 1983 |
Melanoma detection by enzyme-radioimmunoassay of L-dopa, dopamine, and 3-O-methyldopamine in urine.
Topics: Adolescent; Adult; Aged; Deoxyepinephrine; Dopamine; Female; Humans; Immunoenzyme Techniques; Levodopa; Male; Melanoma; Middle Aged; Radioimmunoassay | 1981 |
Effects of dopamine agonists and antagonists on murine melanoma: correlation with dopamine binding activity.
Topics: Animals; Binding, Competitive; Cell Line; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Levodopa; Melanoma; Mice; Neoplasms, Experimental; Pimozide | 1982 |
Chemotherapy of malignant melanoma.
Topics: Daunorubicin; Dicarboxylic Acids; Drug Combinations; Drug Resistance; Humans; Levodopa; Melanocyte-Stimulating Hormones; Melanoma; Methotrexate; Nitrosourea Compounds; Receptors, Estrogen; Tretinoin | 1982 |
Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy.
Topics: Animals; Carbidopa; Diet; Drug Evaluation, Preclinical; Female; Levodopa; Melanoma; Mice; Neoplasms, Experimental; Phenylalanine; Tyrosine | 1982 |
Uveal malignant melanoma and levodopa therapy in Parkinson's disease.
Topics: Aged; Ciliary Body; Female; Humans; Levodopa; Melanoma; Middle Aged; Parkinson Disease; Uveal Neoplasms | 1982 |
An ultrastructural study of albinistic B-14 melanoma cells.
Topics: Animals; Cell Line; Chromatography, Thin Layer; Culture Media; Levodopa; Melanoma; Mice; Mice, Inbred C57BL; Microscopy, Electron; Neoplasms, Experimental; Pigmentation; Tyrosine | 1981 |
An experimental approach to the chemotherapy of melanoma.
Topics: Antineoplastic Agents; Dopamine; Humans; Indoles; Levodopa; Melanins; Melanoma; Skin Neoplasms; Tyrosine | 1980 |
Epidermotropism in melanoma.
Topics: Epidermis; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Nevus; Skin; Skin Neoplasms; Time Factors | 1980 |
Levodopa administration and multiple primary cutaneous melanomas.
Topics: Aged; Female; Humans; Levodopa; Melanoma; Neoplasms, Multiple Primary; Skin Neoplasms; Tremor | 1980 |
O-methylation of L-dopa in melanin metabolism and the presence of catechol-O-methyltransferase in melanocytes.
Topics: 1-Methyl-3-isobutylxanthine; Catechol O-Methyltransferase; Cells, Cultured; Humans; Isoenzymes; Levodopa; Melanins; Melanocytes; Melanoma; Membrane Proteins; Methylation; Microscopy, Immunoelectron; Monophenol Monooxygenase; Neoplasm Proteins; Subcellular Fractions; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1994 |
Effects of alpha- and beta-arbutin on activity of tyrosinases from mushroom and mouse melanoma.
Topics: Animals; Arbutin; Basidiomycota; Binding, Competitive; Chromatography, High Pressure Liquid; Hydroquinones; Levodopa; Magnetic Resonance Spectroscopy; Melanoma; Mice; Monophenol Monooxygenase; Starch | 1995 |
Antimelanoma effect of 4-S-cysteaminylcatechol, an activated form of 4-S-cysteaminylphenol.
Topics: Animals; Antineoplastic Agents; Biotransformation; Cell Division; Cell Line; Cell Survival; Cysteamine; Dose-Response Relationship, Drug; Humans; Kinetics; Levodopa; Melanoma; Melanoma, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Monophenol Monooxygenase; Oxidation-Reduction; Oxidoreductases; Proteins; Tumor Cells, Cultured | 1995 |
New thioureas and related substances intended for melanoma targeting.
Topics: Animals; Autoradiography; Basidiomycota; Benzoquinones; Dihydroxyphenylalanine; Dopamine Agents; Intramolecular Oxidoreductases; Isomerases; Levodopa; Melanins; Melanoma; Mice; Mice, Inbred C57BL; Monophenol Monooxygenase; Neoplasm Transplantation; Oxidation-Reduction; Thiourea; Whole-Body Irradiation | 1995 |
Determination of the L-DOPA/L-tyrosine ratio in human plasma by high-performance liquid chromatography. Usefulness as a marker in metastatic malignant melanoma.
Topics: Biomarkers, Tumor; Calibration; Chromatography, High Pressure Liquid; Circadian Rhythm; Humans; Hydrogen-Ion Concentration; Levodopa; Linear Models; Melanins; Melanoma; Reproducibility of Results; Skin Neoplasms; Spectrometry, Fluorescence; Tyrosine | 1997 |
Safety of long-term levodopa therapy in malignant melanoma.
Topics: Aged; Antiparkinson Agents; Drug Administration Schedule; Humans; Levodopa; Male; Melanoma; Parkinson Disease | 1994 |
Anatomic distribution of melanocytes in normal nail unit: an immunohistochemical investigation.
Topics: Aged; Antibodies, Monoclonal; Antigens, Neoplasm; Antigens, Surface; Cell Count; Cell Differentiation; Coloring Agents; Dopamine Agents; Epidermal Cells; Epithelial Cells; Female; Humans; Immunohistochemistry; Levodopa; Male; Melanins; Melanocytes; Melanoma; Melanoma-Specific Antigens; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Nail Diseases; Nails; Neoplasm Proteins; Oxidoreductases; Pigmentation Disorders; Proteins; Vacuoles | 1997 |
Melanoma and levodopa.
Topics: Antiparkinson Agents; Dopamine Agonists; Humans; Levodopa; Melanoma; Parkinson Disease; Risk Factors; Skin Neoplasms | 1998 |
Development of metastases in malignant melanoma is associated with an increase in the plasma L-dopa/L-tyrosine ratio.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Chromatography, High Pressure Liquid; Female; Follow-Up Studies; Humans; Levodopa; Longitudinal Studies; Male; Melanoma; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Reference Values; Skin Neoplasms; Tyrosine | 1999 |
L-dopa pharmacokinetics studied with microdialysis in patients with Parkinson's disease and a history of malignant melanoma.
Topics: Aged; Antiparkinson Agents; Benserazide; Female; Humans; Levodopa; Male; Melanoma; Microdialysis; Middle Aged; Parkinson Disease; Skin Neoplasms | 1999 |
Hepatocyte growth factor and melanoma: gene transfer studies in human melanocytes.
Topics: Cell Differentiation; Cell Division; Cell Transformation, Neoplastic; DNA, Complementary; Gene Transfer Techniques; Genetic Therapy; Hepatocyte Growth Factor; Humans; Immunohistochemistry; Levodopa; Melanocytes; Melanoma; Microscopy, Phase-Contrast; Phenotype; Retroviridae; Time Factors; Transduction, Genetic; Tumor Cells, Cultured | 2001 |
The cytotoxicity of dopamine may be an artefact of cell culture.
Topics: Animals; Artifacts; Catalase; Cell Death; Culture Media; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Glutathione; Humans; Hydrogen Peroxide; Levodopa; Melanoma; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Nerve Tissue Proteins; Oxidants; Oxidation-Reduction; PC12 Cells; Pheochromocytoma; Rats; Tumor Cells, Cultured | 2002 |
Tyrosine aminotransferase in AKR/J albino and C57BL/6J black mouse skin.
Topics: Amino Acid Oxidoreductases; Animals; Cricetinae; In Vitro Techniques; Kinetics; Levodopa; Melanoma; Mice; Mice, Inbred AKR; Mice, Inbred C57BL; Molecular Weight; Phenylpyruvic Acids; Pigmentation; Skin; Species Specificity; Substrate Specificity; Tyrosine Transaminase | 1978 |
Parkinson's disease, melanoma, and levodopa.
Topics: Aged; Humans; Levodopa; Male; Melanoma; Parkinson Disease; Skin Neoplasms | 1977 |
Modulation of tyrosinase activity and viral information by 5-iodo-deoxyuridine and L-dopa in a human melanoma cell line [proceedings].
Topics: Animals; Antigens, Viral; Catechol Oxidase; Cell Line; Humans; Idoxuridine; Levodopa; Magnesium; Melanoma; Mice; Monophenol Monooxygenase; Neoplasms, Experimental; Oncogenic Viruses; RNA-Directed DNA Polymerase | 1979 |
Effect of alpha-MSH on the tyrosinase activity and the rate of melanin accumulation of melanoma cells in vitro.
Topics: Animals; Catechol Oxidase; Cells, Cultured; In Vitro Techniques; Levodopa; Melanins; Melanocyte-Stimulating Hormones; Melanoma; Mice; Monophenol Monooxygenase; Neoplasms, Experimental; Puromycin; Tyrosine | 1977 |
Incorporation of L-3,4-dihydroxy-[2-14C]phenylalanine into hamster melanoma melanosomes.
Topics: Animals; Carbon Radioisotopes; Cell Fractionation; Cricetinae; Levodopa; Melanocytes; Melanoma; Mesocricetus; Neoplasms, Experimental | 1979 |
Enhancement of L-dopa incorporation into melanoma by dopa decarboxylase inhibition.
Topics: Adrenal Medulla; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Catecholamines; Levodopa; Melanins; Melanoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Rats | 1978 |
Levodopa therapy and malignant melanoma.
Topics: Adult; Age Factors; Aged; Humans; Levodopa; Male; Melanoma; Middle Aged; Parkinson Disease; Skin Neoplasms | 1978 |
[Connection between levodopa therapy and malignant tumors].
Topics: Aged; Female; Humans; Levodopa; Melanoma; Urethral Neoplasms | 1979 |
Levodopa and melanoma.
Topics: Humans; Levodopa; Melanoma; Parkinson Disease; Skin Neoplasms | 1979 |
Pigmented hyperplasia of epidermis following feeding of L-dopa to elderly rats.
Topics: Age Factors; Animals; Humans; Hyperplasia; Levodopa; Male; Melanins; Melanoma; Neoplasms, Experimental; Pigmentation; Precancerous Conditions; Rats; Rats, Inbred BN; Recurrence; Skin; Skin Neoplasms | 1977 |
Selective incorporation of L-3,4-dihydroxyphenylalanine by S-91 Cloudman melanoma in vitro.
Topics: Cells, Cultured; Cycloheximide; Levodopa; Melanins; Melanocyte-Stimulating Hormones; Melanoma; Neoplasms, Experimental; Theophylline; Tyrosine | 1977 |
L-dopa: selective toxicity for melanoma cells in vitro.
Topics: Cell Division; Cell Line; Levodopa; Melanoma; Pigmentation | 1977 |
l-Dopa methyl ester as a new antitumour agent.
Topics: Animals; DNA, Neoplasm; Leukemia, Experimental; Levodopa; Melanoma; Mice; Neoplasms, Experimental | 1977 |
The effect of L-dopa, noradrenalin and adrenalin on P-388 mouse leukemia, B-16 mouse melanoma and E 0771 mammary carcinoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Drug Evaluation, Preclinical; Epinephrine; Female; Leukemia, Experimental; Levodopa; Mammary Neoplasms, Experimental; Melanoma; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Norepinephrine | 1975 |
[Letter: Malignant melanoma during treatment with levodopa].
Topics: Aged; Biopsy; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Parkinson Disease, Secondary; Skin Neoplasms | 1975 |
Lid melanoma and parkinsonism.
Topics: Aged; Eyelid Neoplasms; Female; Humans; Levodopa; Melanoma; Parkinson Disease | 1992 |
L-dopa binding sites in rodent melanoma cells.
Topics: Animals; Binding Sites; Carrier Proteins; Cell Membrane; Cell Nucleus; Cricetinae; Levodopa; Melanoma; Membrane Proteins; Mice; Tumor Cells, Cultured | 1992 |
Impaired levodopa response in Parkinson's disease during melanoma therapy.
Topics: Adult; Dacarbazine; Dopamine; Drug Interactions; Humans; Levodopa; Male; Melanins; Melanoma; Parkinson Disease; Skin Neoplasms | 1992 |
Studies on the reactions between human tyrosinase, superoxide anion, hydrogen peroxide and thiols.
Topics: Anions; Catalase; Chromatography, DEAE-Cellulose; Humans; Hydrogen Peroxide; Indolequinones; Indoles; Levodopa; Melanoma; Monophenol Monooxygenase; Oxidation-Reduction; Quinones; Substrate Specificity; Sulfhydryl Compounds; Superoxides | 1991 |
Hydrogen peroxide as a mediator of dopac-induced effects on melanoma cells.
Topics: 3,4-Dihydroxyphenylacetic Acid; Catalase; Cell Line; Humans; Hydrogen Peroxide; Levodopa; Melanins; Melanoma; Monophenol Monooxygenase; Phenylacetates | 1991 |
Molecular mechanism of tyrosinase regulation by L-dopa in hamster melanoma cells.
Topics: Animals; Cloning, Molecular; Cricetinae; Drug Administration Schedule; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Intracellular Fluid; Levodopa; Melanins; Melanoma; Monophenol Monooxygenase; Protein Biosynthesis; RNA, Messenger; Tumor Cells, Cultured | 1991 |
L-tyrosine-binding proteins on melanoma cells.
Topics: Animals; Antibodies; Blotting, Western; Carbon Radioisotopes; Chromatography, Affinity; Cricetinae; Levodopa; Melanoma; Molecular Weight; Monophenol Monooxygenase; Phenylalanine; Protein Binding; Tumor Cells, Cultured; Tyrosine | 1991 |
[Heterogeneity of tyrosinases isolated from rat skin, normal human skin, and human melanoma tumors].
Topics: Animals; Blotting, Western; Chromatography, Liquid; Electrophoresis, Polyacrylamide Gel; Humans; Isoelectric Focusing; Isoenzymes; Kinetics; Levodopa; Melanoma; Monophenol Monooxygenase; Oxidation-Reduction; Rats; Skin; Skin Neoplasms | 1991 |
The use of L-dopa and carbidopa in metastatic malignant melanoma.
Topics: Carbidopa; Female; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms | 1991 |
The effect of L-dopa on the potentiation of radiation damage to human melanoma cells.
Topics: Cell Cycle; DNA Damage; Dose-Response Relationship, Radiation; Female; HeLa Cells; Humans; Levodopa; Melanoma; Radiation Tolerance | 1990 |
Development of two malignant melanomas during administration of levodopa.
Topics: Aged; Humans; Levodopa; Male; Melanoma; Parkinson Disease; Time Factors | 1985 |
Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
Topics: Buthionine Sulfoximine; Cell Cycle; Cell Survival; Glutathione; Humans; Levodopa; Melanoma; Methionine Sulfoximine; Tumor Cells, Cultured | 1989 |
Levodopa/dopamine analogs as inhibitors of DNA synthesis in human melanoma cells.
Topics: Animals; DNA; Dopamine; Dose-Response Relationship, Drug; Humans; Levodopa; Melanocytes; Melanoma; Mice; Skin Neoplasms | 1989 |
Phosphorylated isomers of L-dopa stimulate MSH binding capacity and responsiveness to MSH in cultured melanoma cells.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; Isomerism; Levodopa; Melanins; Melanocyte-Stimulating Hormones; Melanoma; Monophenol Monooxygenase; Phosphorylation; Tyrosine 3-Monooxygenase | 1987 |
Melanin synthesis and the action of L-dopa and 3,4-dihydroxybenzylamine in human melanoma cells.
Topics: Cell Cycle; Cell Survival; DNA, Neoplasm; Dopamine; Humans; Levodopa; Melanins; Melanoma; Oxidation-Reduction; RNA, Neoplasm; Superoxide Dismutase; Tumor Cells, Cultured | 1989 |
Increase in melanin formation and promotion of cytotoxicity in cultured melanoma cells caused by phosphorylated isomers of L-dopa.
Topics: Animals; Biological Transport; Cell Survival; Cells, Cultured; Levodopa; Melanins; Melanoma; Mice; Monophenol Monooxygenase; Phosphorylation; Solubility | 1986 |
Mechanism of antitumoral activity of catechols in culture.
Topics: Anisoles; Butylated Hydroxyanisole; Catalase; Catechols; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Culture Media; Humans; Hydroquinones; Leukemia, Erythroblastic, Acute; Levodopa; Lymphoma; Melanoma; Monophenol Monooxygenase; Peroxidases; Resorcinols; Superoxide Dismutase; Time Factors | 1987 |
A hypothesis on the etiology of malignant melanoma: the role of chemicals interfering with melanin synthesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Female; Humans; Levodopa; Male; Melanoma; Occupational Diseases; Polychlorinated Biphenyls; Skin Neoplasms; Sunlight | 1987 |
Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway, L-tyrosine and L-dopa.
Topics: Animals; Cricetinae; Levodopa; Melanins; Melanocytes; Melanoma; Monophenol Monooxygenase; Tumor Cells, Cultured; Tyrosine | 1988 |
13C solid-state cross polarization/magic-angle-spinning nuclear magnetic resonance spectra of natural and synthetic melanins.
Topics: Animals; Carbon Isotopes; Choroid; Horse Diseases; Horses; Levodopa; Magnetic Resonance Spectroscopy; Melanins; Melanoma; Oxidation-Reduction; Tyrosine | 1988 |
[Visualization of a lung metastatic lesion from malignant melanoma by N-isopropyl-p-123I-iodoamphetamine: usefulness of L-dopa load scintigraphy].
Topics: Aged; Amphetamines; Female; Humans; Iofetamine; Levodopa; Lung Neoplasms; Melanoma; Nose Neoplasms; Radionuclide Imaging | 1987 |
Inhibition of transformation by levodopa-carbidopa in lymphocytes derived from patients with melanoma.
Topics: Carbidopa; Dopamine; Drug Combinations; Humans; Levodopa; Lymphocyte Activation; Melanoma; Osmolar Concentration; Phytohemagglutinins | 1987 |
The cytotoxicity of cysteinylcatechols and related compounds to human melanoma cells in vitro.
Topics: Antineoplastic Agents; Catechols; Cell Division; Cell Line; Cell Survival; Cysteine; Dose-Response Relationship, Drug; Humans; Levodopa; Melanoma; Phenols; Time Factors | 1987 |
Interaction between specific dietary factors and experimental chemotherapy of metastatic melanoma.
Topics: Animals; Ascorbic Acid; Diet; Female; Levodopa; Lung Neoplasms; Melanoma; Mice; Mice, Inbred Strains; Phenylalanine; Tyrosine | 1986 |
Pretreatment effects on the uptake/retention kinetics of L-dopa in Harding-Passey melanoma.
Topics: Adrenal Glands; Animals; Injections, Intraperitoneal; Kinetics; Levodopa; Melanoma; Metabolic Clearance Rate; Mice; Premedication | 1986 |
Modulation of peroxidation in murine melanoma by dietary tyrosine-phenylalanine restriction, levodopa methylester chemotherapy, and sodium ascorbate supplementation.
Topics: Animals; Ascorbic Acid; Diet; Female; Levodopa; Lipid Peroxides; Liver; Malondialdehyde; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Phenylalanine; Tyrosine | 1985 |
The involvement of histidine at the active site of Harding-Passey mouse melanoma tyrosinase.
Topics: Animals; Binding Sites; Catechol Oxidase; Cell Line; Histidine; Hydrogen-Ion Concentration; Kinetics; Levodopa; Melanoma; Mice; Mice, Inbred C57BL; Monophenol Monooxygenase; Oxidation-Reduction; Photochemistry | 1985 |
Plasma L-dopa in the diagnosis of malignant melanoma.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Staging; Skin Neoplasms | 1986 |
Levodopa and melanoma: three cases and review of literature.
Topics: Aged; Female; Humans; Levodopa; Male; Melanoma; Parkinson Disease; Skin Neoplasms | 1985 |
Development of malignant melanoma after levodopa therapy for Parkinson's disease. Report of a case and review of the literature.
Topics: Female; Humans; Levodopa; Melanoma; Middle Aged; Nevus, Pigmented; Parkinson Disease; Skin Neoplasms | 1985 |
Stimulation of pheomelanogenesis in cultured B16 melanoma cells by 4-tertiary butylcatechol.
Topics: Animals; Catechols; Cell Line; Chromatography, High Pressure Liquid; Cysteinyldopa; Dose-Response Relationship, Drug; Glutathione; Kinetics; Levodopa; Melanins; Melanoma; Mice | 1985 |
Metabolic characterization of three hamster melanoma variants.
Topics: Animals; Cell Line; Citrates; Citric Acid; Citric Acid Cycle; Cricetinae; Glucose; Glutamine; Glycolysis; Levodopa; Melanoma; Mesocricetus; Pentose Phosphate Pathway | 1985 |
[Malignant melanoma and L-dopa. Review of literature on the problem of causal relationship].
Topics: Humans; Levodopa; Male; Melanins; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Parkinson Disease; Skin Neoplasms; Tryptophan | 1974 |